Herbalife Q3 profit beat estimates on North America stregnth

Herbalife

05/11/2025 21:19

Overview

Herbalife Q3 net sales up 2.7% yr/yr, above co's guidance midpoint

Adjusted EBITDA for Q3 exceeds co's guidance, reflecting strong operational execution

Adjusted EPS for Q3 beats analyst expectations

Outlook

Herbalife tightens full-year 2025 guidance ranges for net sales and adjusted EBITDA

Company sees Q4 2025 net sales growth of 1.5% to 5.5% YoY

Herbalife expects full-year 2025 adjusted EBITDA between $645 mln and $655 mln

Result Drivers

NORTH AMERICA GROWTH - North America net sales increased by 1.0% yr/yr, marking the region’s first quarterly gain since Q2 '21

PRO2COL APP EXPANSION - Expanded access to beta version of Pro2col app to retail customers, enhancing distributor operations

ADJUSTED EBITDA EXCEEDS GUIDANCE - Adjusted EBITDA of $163.0 mln exceeded guidance, despite $12 mln foreign currency headwinds

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Adjusted EPS
Beat
$0.50
$0.47 (1 Analyst)
Q3 EPS
$0.42
Q3 Net Income
$43.20 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the food processing peer group is "buy."

Wall Street's median 12-month price target for Herbalife Ltd is $10.50, about 24% above its November 4 closing price of $7.98

The stock recently traded at 3 times the next 12-month earnings vs. a P/E of 4 three months ago

Press Release: ID:nBw763hS2a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)